licensed certain IP from Regen to start pre clinical trial testing by December. So far nothing has come to fruition. The deal goes south if Onco can not get the testing done by December. All the details is listed in the SEC filing when the deal was announced. Onco looks to have over promised its ability to get funding. But there is still time so I can always be proven wrong.
News 
Market Data 
Discover 
